AHAmanda Heidt

1. Article · Aug 17, 2026 · Amanda Heidt

   First-of-its-kind narcolepsy drug opens door to new therapies for the brain (opens the original)

   Excerpt · English

   Read excerpt

   Earlier this month, the US Food and Drug Administration approved the first drug designed to treat the root cause of narcolepsy, a condition that affects millions of people by causing extreme sleepiness during the day and wakefulness at night. Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription Receive 52 print issues and online access Prices may be subject to local taxes which are calculated during checkout doi: https://doi.org/10.1038/d415

   Feedback

2. Article · Jul 16, 2026 · Amanda Heidt

   CRISPR gets a power boost from AI-designed ‘molecular scissors’ (opens the original)

   Excerpt · Neutral tone · English

   Read excerpt

   Scientists have harnessed artificial-intelligence models to create synthetic CRISPR proteins that edit the genome more efficiently than their naturally occurring counterparts. Such synthetic CRISPR systems could one day power discoveries in fields from medicine to agriculture. Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription Receive 52 print issues and online access Prices may be subject to local taxes which are calculated during checkou

   Feedback

Last 90 days. Choose a month to open its work.

Named in the text we hold. One piece can cover several.

• Stanford University1 piece
• Mount Everest1 piece
• Drug Administration1 piece